Antibiotice Iași reported a 52% decrease in net profit in the first nine months of 2025, despite the stabilization of exports and significant investments in development.

The pharmaceutical company Antibiotice Iași, owned by the Ministry of Health, recorded a significant decrease in net profit of 52%, reaching 42.63 million lei in the first nine months of 2025. Total revenues decreased by 3%, reaching 498.2 million lei, while current liabilities increased by 13%, reaching 265 million lei.

Despite these challenges, Antibiotice Iași is carrying out an investment project of 375 million lei, aimed at developing the research and development center and a new production capacity. Exports remained stable, generating revenues of 202.6 million lei, with a 3% increase in exports of finished products. In the domestic market, revenues decreased by 12.5%, but the company maintains a solid market share in generic medicines. Antibiotice Iași remains optimistic about future growth, relying on strategic partnerships and expansion into new markets.